Sanjeev Sethi Selected Research

Paraproteinemias (Monoclonal Gammopathy)

11/2021	Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy: A Validation Study.
1/2021	Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits.
1/2020	DNAJB9-positive monotypic fibrillary glomerulonephritis is not associated with monoclonal gammopathy in the vast majority of patients.
4/2018	High-dose melphalan and autologous hematopoietic stem cell transplant in patient with C3 glomerulonephritis associated with monoclonal gammopathy .
1/2018	C3 glomerulopathy associated with monoclonal Ig is a distinct subtype.
1/2017	Thrombotic microangiopathy associated with monoclonal gammopathy.
3/2016	Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.
7/2015	Bortezomib-induced acute interstitial nephritis.
6/2015	Refractory atypical hemolytic uremic syndrome with monoclonal gammopathy responsive to bortezomib-based therapy.
4/2015	Diagnosis of monoclonal gammopathy of renal significance.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sanjeev Sethi Research Topics

Disease

44	Glomerulonephritis 01/2022 - 08/2003
36	Proteinuria 01/2021 - 02/2006
27	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2022 - 09/2004
25	Amyloidosis 10/2020 - 12/2010
22	Membranous Glomerulonephritis (Membranous Nephropathy) 11/2021 - 05/2008
19	Paraproteinemias (Monoclonal Gammopathy) 11/2021 - 11/2010
12	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 06/2010
11	Renal Insufficiency (Renal Failure) 01/2022 - 05/2005
10	Infections 01/2022 - 12/2012
9	Kidney Diseases (Kidney Disease) 01/2022 - 12/2012
9	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 05/2008
9	Atypical Hemolytic Uremic Syndrome 01/2021 - 06/2014
9	Thrombotic Microangiopathies 01/2021 - 02/2006
9	Hematuria 01/2020 - 08/2010
8	Amyloid Plaque 01/2022 - 07/2012
8	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 01/2004
8	Vasculitis (Vasculitides) 01/2022 - 03/2010
8	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2019 - 07/2011
7	Acute Kidney Injury (Acute Renal Failure) 03/2021 - 11/2010
6	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022 - 09/2011
5	Lupus Nephritis 01/2022 - 10/2012
5	Neoplasms (Cancer) 11/2021 - 05/2011
5	Multiple Myeloma 03/2021 - 11/2010
5	Fibrosis (Cirrhosis) 03/2021 - 04/2008
4	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 01/2022 - 04/2007
4	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2022 - 04/2008
4	Atrophy 03/2021 - 04/2008
4	Microscopic Polyangiitis 01/2019 - 09/2009
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018 - 09/2013
3	Inflammation (Inflammations) 01/2022 - 02/2013
3	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2019 - 05/2011
3	Familial Amyloidosis (Hereditary Amyloidosis) 02/2017 - 07/2011
3	Chronic Renal Insufficiency 01/2017 - 01/2012
3	Monoclonal Gammopathy of Undetermined Significance 11/2013 - 11/2010
3	Diabetic Nephropathies (Diabetic Nephropathy) 06/2012 - 01/2011
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 10/2021 - 01/2019
2	COVID-19 10/2021 - 04/2021
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 10/2021 - 04/2014
2	Malignant Hypertension 01/2021 - 02/2006
2	Lymphoma (Lymphomas) 01/2018 - 11/2013
2	Nephritis 04/2016 - 07/2014

Drug/Important Bio-Agent (IBA)

32	Complement System Proteins (Complement)IBA 01/2022 - 05/2009
26	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2002
25	CreatinineIBA 01/2022 - 06/2010
21	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2010
20	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 05/2009
18	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 08/2003
14	Amyloid (Amyloid Fibrils)IBA 10/2020 - 11/2010
12	Rituximab (Mabthera)FDA Link 11/2020 - 09/2007
12	Dichlorodiphenyldichloroethane (DDD)IBA 01/2019 - 09/2007
11	Immunoglobulin G (IgG)IBA 01/2020 - 04/2007
9	Congo RedIBA 01/2022 - 07/2011
8	AntibodiesIBA 11/2021 - 09/2009
7	AntigensIBA 01/2021 - 03/2012
6	Prednisone (Sone)FDA LinkGeneric 01/2022 - 05/2011
6	AA amyloidosisIBA 10/2019 - 06/2011
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2017 - 05/2011
5	Pharmaceutical PreparationsIBA 01/2021 - 08/2003
5	ApolipoproteinsIBA 01/2018 - 01/2013
5	GelsolinIBA 01/2018 - 01/2012
5	Chemotactic FactorsIBA 02/2017 - 09/2013
4	Phospholipase A2 ReceptorsIBA 11/2021 - 03/2012
4	SteroidsIBA 01/2019 - 08/2011
4	eculizumab FDA Link 01/2019 - 09/2007
4	Complement Factor H (Factor H)IBA 10/2018 - 07/2012
4	Amyloidogenic ProteinsIBA 01/2018 - 05/2013
4	Fibrinogen (Factor I)FDA Link 01/2018 - 01/2012
4	Bortezomib (Velcade)FDA Link 07/2015 - 09/2013
4	Serum Amyloid A Protein (Serum Amyloid A)IBA 10/2013 - 07/2011
3	CryoglobulinsIBA 01/2022 - 02/2017
3	Complement C3 (C3 Complement)IBA 01/2022 - 06/2014
3	Immunoglobulin A (IgA)IBA 03/2021 - 05/2015
3	ParaffinIBA 01/2020 - 07/2014
3	ThrombospondinsIBA 01/2019 - 02/2015
3	Peroxidase (Myeloperoxidase)IBA 01/2019 - 09/2009
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019 - 03/2010
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 09/2013
3	Serum Amyloid P-ComponentIBA 01/2018 - 01/2013
3	AutoantibodiesIBA 02/2017 - 07/2011
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2013 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
2	Semaphorins (Semaphorin)IBA 01/2021 - 11/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 08/2003
2	AngiotensinsIBA 01/2019 - 01/2019
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 01/2015
2	Myeloblastin (Proteinase 3)IBA 01/2019 - 08/2003
2	Complement Factor B (Factor B)IBA 10/2018 - 03/2015
2	Apolipoprotein C-II (ApoC2)IBA 09/2018 - 02/2017
2	Peptides (Polypeptides)IBA 01/2018 - 02/2017
2	Serum AlbuminIBA 12/2017 - 08/2014
2	Apolipoproteins E (ApoE)IBA 01/2017 - 07/2015
2	ParaproteinsIBA 06/2016 - 06/2012
2	antiglomerular basement membrane antibodyIBA 04/2016 - 07/2014

Therapy/Procedure

16	Lasers (Laser) 11/2020 - 12/2010
15	Therapeutics 01/2022 - 08/2003
9	Drug Therapy (Chemotherapy) 03/2021 - 09/2004
3	Plasma Exchange 01/2022 - 07/2006
3	Kidney Transplantation 10/2020 - 04/2008
3	Renal Dialysis (Hemodialysis) 01/2019 - 04/2016
2	Transplantation 01/2021 - 03/2013